However, the exogenous administration of GLP-1RAs can mitigate sympathetic excitability by suppressing the peripheral chemoreflex originating from the carotid body.467 Under hyperglycemic conditions, GLP-1RAs regulate hypertension by inhibiting carotid body function.468 Specifically, these agents can attenuate the excitability of carotid body cells and diminish sympathetic activation, ultimately leading to a reduction in sympathetic responses.465 This modulatory effect holds promise for ameliorating sympathetic activity in individuals with hypertension, as these agents lower blood pressure levels.469 Importantly, the GLP-1-carotid body pathway may represent a novel therapeutic target for managing cardiovascular metabolism and treating patients with diabetes and hypertension who exhibit heightened sympathetic activity.465 (Fig
A deficiency can creep up gradually, making it easy to dismiss symptoms as stress or simply getting older. However, if left untreated, low B12 levels can lead to serious health issues
Finally, tirzepatide for weight loss did not receive traditional FDA approval
Phone support is not available
Comparison to Competitors In a recent head-to-head study, Eli Lillys Mounjaro (tirzepatide) reported a 20.2% weight loss after 72 weeks, outperforming Wegovys 2.4mg dose, which achieved 13.7%
